| Report Title | Price | Action |
|---|---|---|
| Nonstructural Protein 1 (NS1) - Drugs in Development, 2021
Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 Summary Nonstructural Protein 1 (NS1) - Drugs in Development, 2021 provides in depth anal...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Transient Receptor Potential Cation Channel Subfamily V Member 4 (Osm 9 Like TRP Channel 4 or Vanilloid Receptor Like Protein 2 or TRPV4) - Drugs in Development, 2021
Transient Receptor Potential Cation Channel Subfamily V Member 4 (Osm 9 Like TRP Channel 4 or Vanilloid Receptor Like Protein 2 or TRPV4) - Drugs in D...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021
Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 Summary Lymphoblastic Lymphoma (Oncology) - Drugs in Development, 2021 provides an ov...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Thrombocytopenia (Hematological Disorders) - Drugs in Development, 2021
Thrombocytopenia (Hematological Disorders) - Drugs in Development, 2021 Summary Thrombocytopenia (Hematological Disorders) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Memory Impairment (Central Nervous System) - Drugs in Development, 2021
Memory Impairment (Central Nervous System) - Drugs in Development, 2021 Summary Memory Impairment (Central Nervous System) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
| Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) - Drugs in Development, 2021
Ornithine Carbamoyltransferase Mitochondrial (Ornithine Transcarbamylase or OTC or EC 2.1.3.3) - Drugs in Development, 2021 Summary Ornithine Carbam...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Translocator Protein (Mitochondrial Benzodiazepine Receptor or PKBS or Peripheral Type Benzodiazepine Receptor or PBR or TSPO) - Drugs in Development, 2021
Translocator Protein (Mitochondrial Benzodiazepine Receptor or PKBS or Peripheral Type Benzodiazepine Receptor or PBR or TSPO) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Ocular Melanoma (Oncology) - Drugs in Development, 2021
Ocular Melanoma (Oncology) - Drugs in Development, 2021 Summary Ocular Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Thrombosis (Cardiovascular) - Drugs in Development, 2021
Thrombosis (Cardiovascular) - Drugs in Development, 2021 Summary Thrombosis (Cardiovascular) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 105
|
$ 2000 | |
| Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021
Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) - Drugs in Development, 2021 Summary Vasomotor Symptoms of Menopause (Hot Flashes) (W...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) - Drugs in Development, 2021
Programmed Cell Death 1 Ligand 2 (Butyrophilin B7 DC or CD273 or PDCD1LG2) - Drugs in Development, 2021 Summary Programmed Cell Death 1 Ligand 2 (Bu...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Trifunctional Purine Biosynthetic Protein Adenosine 3 (Phosphoribosylglycinamide Formyltransferase or Phosphoribosylamine Glycine Ligase or Phosphoribosylformylglycinamidine Cyclo Ligase or GART or EC 2.1.2.2 or EC 6.3.3.1 or EC 6.3.4.13) - Drugs in Development, 2021
Trifunctional Purine Biosynthetic Protein Adenosine 3 (Phosphoribosylglycinamide Formyltransferase or Phosphoribosylamine Glycine Ligase or Phosphorib...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Squamous Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021
Squamous Non-Small Cell Lung Carcinoma (Oncology) - Drugs in Development, 2021 Summary Squamous Non-Small Cell Lung Carcinoma (Oncology) - Drugs in ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021
Transitional Cell Cancer (Urothelial Cell Cancer) (Oncology) - Drugs in Development, 2021 Summary Transitional Cell Cancer (Urothelial Cell Cancer) ...
Published: Apr-2021 | No. of Pages: 160
|
$ 2000 | |
| Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021
Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 Summary Metabolic Syndrome (Metabolic Disorders) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 60
|
$ 2000 | |
| Proto Oncogene Mas (MAS1) - Drugs in Development, 2021
Proto Oncogene Mas (MAS1) - Drugs in Development, 2021 Summary Proto Oncogene Mas (MAS1) - Drugs in Development, 2021 provides in depth analysis on ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) - Drugs in Development, 2021
Triggering Receptor Expressed On Myeloid Cells 2 (Triggering Receptor Expressed On Monocytes 2 or TREM2) - Drugs in Development, 2021 Summary Trigge...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Testicular Cancer (Oncology) - Drugs in Development, 2021
Testicular Cancer (Oncology) - Drugs in Development, 2021 Summary Testicular Cancer (Oncology) - Drugs in Development, 2021 provides an overview of ...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
| Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) (Oncology) - Drugs in Development, 2021 Summary Transitional Cell Carcinoma (Urothelial Cell...
Published: Apr-2021 | No. of Pages: 170
|
$ 2000 | |
| Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021
Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 Summary Metastatic Adenocarcinoma of The Pancreas (Oncology) - Dru...
Published: Apr-2021 | No. of Pages: 140
|
$ 2000 |